MALMÖ, Sweden--(BUSINESS WIRE)--Regulatory News:
Hansa Medical (STO:HMED)
Hansa Medical has been informed that a small group of long-term institutional investors have acquired shares from Farstorps Gård AB
Following the divestiture, Farstorps Gård AB holds approximately 1 million shares in Hansa Medical, equivalent to approximately 3 percent of the number of outstanding shares in Hansa Medical. Farstorps Gård AB has informed Hansa Medical that Farstorps Gård AB will remain a long-term shareholder in the company and that Farstorps Gård has committed not to divest any further shares within the next 12 months (a so called 12 month lock-up period).
